Arcoma AB (SE:ARCOMA)

:ARCOMA

ARCOMA

Arcoma AB

RESEARCH TOOLSreports

Want to see SE:ARCOMA full AI Analyst Report?

Arcoma AB (ARCOMA) Price & Analysis

0 Followers

ARCOMA Stock Chart & Stats

kr7.20

-kr0.40(-3.79%)

At close: Mar 06 4:00 PM EST

kr7.20

-kr0.40(-3.79%)

Day’s Range― - ―

52-Week Rangekr6.16 - kr11.00

Previous CloseN/A

Volume10.05K

Average Volume (3M)22.73K

Market Cap

kr123.91M

Enterprise Valuekr100.27M

Total Cash (Recent Filing)kr33.94M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)35.3

Beta0.14

Next Earnings

Aug 20, 2026

EPS Estimate

0.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.26

Shares Outstanding14,308,510

10 Day Avg. Volume31,356

30 Day Avg. Volume22,732

Financial Highlights & Ratios

PEG Ratio-0.35

Price to Book (P/B)1.41

Price to Sales (P/S)0.80

P/FCF Ratio5.68

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.63

Revenue Forecast (FY)kr137.00M

Bulls Say, Bears Say

Bulls Say

Balance Sheet Strength (zero Debt)Zero debt materially reduces financial risk and gives management flexibility to fund R&D, service expansion, or absorb demand shocks without interest burdens. Over 2–6 months this supports stability in capital allocation and resilience through elective investment or opportunistic acquisitions.

Robust Cash GenerationSustained operating and free cash flow provides durable internal financing for capex, spare-parts inventory, and service operations. Strong cash conversion enhances self-funding of growth, reduces refinancing needs, and supports steady investment in product development and installed-base service.

Aftermarket / Recurring Service RevenueA business model anchored in equipment sales plus recurring service and parts creates higher customer retention and steady follow-on revenue. Over months this installed-base revenue smooths cycles in new-system sales and improves lifetime value per customer, supporting margin durability.

Bears Say

Declining Revenue TrendMaterial negative revenue growth indicates demand or shipment softness that can erode service growth and margin leverage. If top-line contraction continues over several quarters, it will pressure utilization of fixed costs and make sustaining recent cash generation and profitability harder.

Volatile Margins And Earnings ConsistencyLarge year-to-year margin swings reduce predictability of earnings and cash flow, complicating planning for R&D and spare-parts inventories. Persistent volatility can undermine investor and customer confidence and increases execution risk for maintaining returns without leverage.

Small Scale / Limited ResourcesA very small workforce constrains sales coverage, product development pace, and ability to scale service operations internationally. Over the medium term this limits market penetration and increases dependency on a few key personnel, raising operational and execution risk as the company pursues growth.

ARCOMA FAQ

What was Arcoma AB’s price range in the past 12 months?

Arcoma AB lowest stock price was kr6.16 and its highest was kr11.00 in the past 12 months.

What is Arcoma AB’s market cap?

Arcoma AB’s market cap is kr123.91M.

When is Arcoma AB’s upcoming earnings report date?

Arcoma AB’s upcoming earnings report date is Aug 20, 2026 which is in 88 days.

How were Arcoma AB’s earnings last quarter?

Arcoma AB released its earnings results on Apr 23, 2026. The company reported kr0.06 earnings per share for the quarter, missing the consensus estimate of kr0.18 by -kr0.12.

Is Arcoma AB overvalued?

According to Wall Street analysts Arcoma AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Arcoma AB pay dividends?

Arcoma AB does not currently pay dividends.

What is Arcoma AB’s EPS estimate?

Arcoma AB’s EPS estimate is 0.14.

How many shares outstanding does Arcoma AB have?

Arcoma AB has 14,308,510 shares outstanding.

What happened to Arcoma AB’s price movement after its last earnings report?

Arcoma AB reported an EPS of kr0.06 in its last earnings report, missing expectations of kr0.18. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Arcoma AB?

Currently, no hedge funds are holding shares in SE:ARCOMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Arcoma AB

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.